We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Guidance Documents On Exploratory INDs
FDA Issues Guidance Documents On Exploratory INDs
February 6, 2006
The FDA has released a series of guidances and a final rule aimed at speeding products to market by streamlining the investigational new drug (IND) application process.